MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Clinical trial NCT02962947 · UNKNOWN
Trial details
- NCT number
- NCT02962947
- Sponsor
- Azienda Sanitaria di Firenze
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2019-06-01
- Enrollment
- 546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.